Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma

Published:2014-11-21 Issue:12 Volume:5 Page:899-911
ISSN:1674-800X
Container-title:Protein & Cell
language:en
Short-container-title:Protein Cell

Author:

Deng Shuanglin,Zhu Shan,Qiao Yuan,Liu Yong-Jun,Chen Wei,Zhao Gang,Chen Jingtao

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Drug Discovery,Biochemistry,Biotechnology

Link

http://link.springer.com/article/10.1007/s13238-014-0112-6/fulltext.html

Reference105 articles.

1. Adams S, O’Neill DW, Nonaka D, Hardin E, Chiriboga L, Siu K, Cruz CM, Angiulli A, Angiulli F, Ritter E et al (2008) Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant. J Immunol 181:776–784

2. Agrawal S, Gupta S (2011) TLR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors. J Clin Immunol 31:89–98

3. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499–511

4. Ali S, Curtin JF, Zirger JM, Xiong W, King GD, Barcia C, Liu C, Puntel M, Goverdhana S, Lowenstein PR et al (2004) Inflammatory and anti-glioma effects of an adenovirus expressing human soluble Fms-like tyrosine kinase 3 ligand (hsFlt3L): treatment with hsFlt3L inhibits intracranial glioma progression. Mol Ther 10:1071–1084

5. Alizadeh D, Zhang L, Brown CE, Farrukh O, Jensen MC, Badie B (2010) Induction of anti-glioma natural killer cell response following multiple low-dose intracerebral CpG therapy. Clin Cancer Res 16:3399–3408

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the landscape of cytokine research in glioma immunotherapy: a scientometrics analysis;Frontiers in Pharmacology;2024-01-08

2. Applications of nanotechnology in remodeling the tumour microenvironment for glioblastoma treatment;Biomaterials Science;2024

3. Glioma-derived ANXA1 suppresses the immune response to TLR3 ligands by promoting an anti-inflammatory tumor microenvironment;Cellular & Molecular Immunology;2023-12-04

4. Lymph node-inspired immunoregulatory hydrogel with siRNA delivery property for postoperative glioblastoma treatment;Chemical Engineering Journal;2023-11

5. Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives;Frontiers in Immunology;2023-09-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3